Radiology
Ultrasound and diagnostic imaging equipment.
KawaHive & Partners provides go-to-market (GTM) strategy for founders with registered MedTech and medical devices in APAC, focusing on hospital demand, distributor sell-through and customer orders.
Your product is registered, but customer interest, distributor activity or market engagement is not yet translating into consistent orders.
A focused, no-obligation conversation to clarify your next go-to-market decision.
Our industry experience spans six market segments. These are areas of familiarity, not separate service lines or claims of KawaHive client delivery.
Ultrasound and diagnostic imaging equipment.
Surgical equipment, instruments and operating room technologies.
Obstetric and gynaecological diagnostic and treatment devices.
Urological diagnostic, endoscopic and treatment devices.
Rehabilitation equipment, therapeutic technologies and mobility devices.
Endoscopy, digestive health diagnostic and treatment devices.
Illustrative situations drawn from prior professional experience before KawaHive. These examples are not KawaHive client engagements.
Every engagement starts with understanding the real go-to-market challenge. Begin with a free assessment; if we are the right fit, you can choose to work with KawaHive through a structured 10-week sprint.
US$0
Who it is for
Founders with a registered product in the MedTech and medical devices sector in their target market who are not yet getting consistent customer orders.
What happens
What you receive
The action plan is yours to keep. There is no obligation to proceed with paid support.
US$3,500 · Fixed fee
For founders with a registered product in the MedTech and medical devices sector whose go-to-market problem is costing orders. Diagnose what is holding orders back, decide what to fix first and test the fix against real customer or distributor evidence.
One clear decision matters: If the evidence says a market, account or distributor relationship is not worth pursuing, we will tell you. We will not recommend continuing just to keep the activity going.
US$3,500 fixed for the ten-week scope. Any work beyond the sprint is scoped and priced separately before it begins. No guarantee of sales or purchase orders.
See the 10-Week Sprint →The free call is no-obligation. The 10-week sprint is US$3,500 fixed; any work beyond ten weeks is scoped and priced separately before it begins.
Take your time. While you consider your next steps, explore our free tools, training and practical GTM insights for founders with a registered product in the MedTech and medical devices sector.
Have an idea for a resource that would help you tackle a go-to-market challenge? Email us and tell us what would be useful. Your suggestions can help shape what we create next.
Is your distributor building customer demand—or simply holding stock? Assess customer access, installed-base certainty, operational continuity and financial runway before deciding what to do next.
Explore practical resources and training to help you think through your medical device go-to-market challenges.
Explore free resources →Read perspectives on APAC markets, hospital buying behaviour, customer priorities and distributor performance.
Explore free insights →No. We do not prepare regulatory submissions or provide regulatory consulting or compliance services. We focus on go-to-market decisions: customer prioritisation, target-market priorities, distributor performance, positioning and the steps that can turn regulatory progress into customer traction.
No. We do not sell marketing campaigns or act as an outsourced marketing team. We help you understand the go-to-market problem first — for example, why hospital interest is not converting into purchase orders, or why a distributor is not generating sustained demand — and clarify which decisions to address next.
No. We can help you assess your options. The Free MedTech Prospecting Training with ICP Scorecard will be most useful once you have a target market or customer segment in mind.
The 10-week sprint has a fixed fee of US$3,500, payable in full before it begins. You may cancel at no charge before both the start date and first session are confirmed. Once both are confirmed, the sprint is non-cancellable and non-refundable. Sessions can be rescheduled free of charge with at least five business days’ notice. Less than five business days’ notice incurs a US$380 short-notice rescheduling fee per session, payable before the rescheduled session. A missed session without prior rescheduling counts as delivered and cannot be refunded or rebooked. If KawaHive needs to reschedule, a replacement date will be arranged at no cost.
The 10-week sprint is for MedTech and medical devices already registered in the target market. While registration is pending, you can use the free tools and Insights in KawaHive Lab. You are welcome to book a call once the product is registered in your target market.
No. The sprint can start with founders who already have hospital or distributor activity but few orders, as well as founders with a registered product but no hospital, distributor or buyer conversations yet. We will discuss fit during the free call.
Talk it through with us — free, no obligation. We’ll help you identify the real issue and the decision that needs attention first.